Acasti Pharma Inc.
ACST
株式のランク
#29744
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
株価
$0.4256834
最終同期: 2023-03-27
時価総額
$18.99M
変化（1日）
3.08%
変化（1年）
-87.02%
国
CA
取引 Acasti Pharma Inc. (ACST)
カテゴリー
Healthcare
Acasti Pharma Inc.（ACST）のEPS
June 2026 時点のEPS TTM: $-1.17
Acasti Pharma Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は$-1.17です。2024年末には、EPSは$-1.35で、2023年のEPS$-5.71と減少でした。
Acasti Pharma Inc.のEPS履歴（2010から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2026 (TTM) | $-1.17 | 48.10% |
| 2025 | $-0.79 | -41.48% |
| 2024 | $-1.35 | -76.36% |
| 2023 | $-5.71 | 256.88% |
| 2022 | $-1.60 | -79.90% |
| 2021 | $-7.96 | -5.01% |
| 2020 | $-8.38 | 73.17% |
| 2019 | $-4.84 | -19.49% |
| 2018 | $-6.01 | -61.25% |
| 2016 | $-15.51 | 224.41% |
| 2015 | $-4.78 | -91.08% |
| 2014 | $-53.58 | 24.03% |
| 2013 | $-43.20 | -8.51% |
| 2012 | $-47.22 | 102.66% |
| 2011 | $-23.30 | -26.64% |
| 2010 | $-31.76 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| $17.32 | -1,580.34% |
US
|
|
| $-7.98 | 582.05% |
US
|
|
| $-5.29 | 352.14% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,470.94% |
NL
|
